Provided by Tiger Fintech (Singapore) Pte. Ltd.

Absci Corporation.

3.03
+0.19006.69%
Post-market: 3.040.0099+0.33%19:42 EDT
Volume:3.23M
Turnover:9.69M
Market Cap:386.50M
PE:-3.28
High:3.07
Open:2.87
Low:2.86
Close:2.84
Loading ...

Absci Corporation to Present at Jefferies Global Healthcare Conference in New York

Reuters
·
20 May

Absci Price Target Maintained With a $9.00/Share by Needham

Dow Jones
·
14 May

AbSci’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating

TIPRANKS
·
14 May

Absci Shares Rise as Phase 1 Study Begins, Partnerships to Increase

Dow Jones
·
14 May

Absci Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Absci Q1 Revenue USD 1.179 Million

Reuters
·
14 May

Absci Q1 EPS $(0.21) Beats $(0.22) Estimate, Sales $1.20M Beat $1.07M Estimate

Benzinga
·
14 May

Absci Corp: Cash, Cash Equivalents, and Short-Term Investments Sufficient to Fund Operations Into First Half of 2027

THOMSON REUTERS
·
14 May

Absci Q1 Revenue USD 1.179 Million

THOMSON REUTERS
·
14 May

Press Release: Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Dow Jones
·
14 May

BRIEF-Absci Announces First Participants Dosed In Phase 1 Clinical Trial Of Abs-101, A Potential Best-In-Class Anti-TL1a Antibody For The Treatment Of Inflammatory Bowel Disease

Reuters
·
14 May

Absci Corporation Launches Phase 1 Clinical Trial for AI-Designed Anti-TL1A Antibody ABS-101, Targeting Inflammatory Bowel Disease

Reuters
·
14 May

Absci Corp - Abs-101 Shows High Potency and Quarterly Dosing Potential

THOMSON REUTERS
·
14 May

Absci Corp: Interim Data Anticipated in Second Half of 2025

THOMSON REUTERS
·
14 May

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of Abs-101, a Potential Best-in-Class Anti-Tl1a Antibody for the Treatment of Inflammatory Bowel Disease

THOMSON REUTERS
·
14 May

AbSci Corp options imply 13.4% move in share price post-earnings

TIPRANKS
·
14 May

Absci Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
10 May

24H|Crypto Shares Gain; Canaan up 10%; Riot Platforms up 5%; Medical AI Stocks Rise; RXRX up 4%; Gold Shares Fall

Tiger Newspress
·
07 May

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress
·
02 May

KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)

TIPRANKS
·
16 Apr